ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2013

Is fidaxomicin worth the cost? An economic analysis.

Sarah M Bartsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.